MedTrace Logo

Effects of Supplementation With Tocotrienol on Chronic Kidney Disease Patients

NCT04900532 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2024-02-26

No results posted yet for this study

Summary

The objective of this study is to evaluate the supplementation with tocotrienol, a vitamin E compound on inflammation, oxidative stress, and microbiota on Chronic Kidney Disease patients.

Conditions

  • Chronic Kidney Diseases
  • Hemodialysis
  • Microbiota
  • Oxidative Stress
  • Inflammation

Interventions

DIETARY_SUPPLEMENT

Tocotrienol rich fraction

Supplementation with a Vitamin E compound.

DIETARY_SUPPLEMENT

Placebo

Administration of placebo containing 0,96mg of tocotrienol and 1,76mg of tocopherol twice a day for three months.

Sponsors & Collaborators

  • Wayne State University

    collaborator OTHER

  • Universidade Federal Fluminense

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2019-08-01
Completion
2023-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04900532 on ClinicalTrials.gov